DOXORUBICIN HYDROCHLORIDE - doxorubicin hydrochloride injectable, liposomal
Zydus Lifesciences Limited
----------
NDC 49315-008-03
DOXOrubicin Hydrochloride Liposome Injection
20 mg/10 mL
(2 mg/mL)
Cytotoxic Agent Must be diluted
LIPOSOMAL FORMULATION – DO NOT SUBSTITUTE FOR DOXORUBICIN HCL
FOR INTRAVENOUS INFUSION ONLY
10 mL Single-Dose Vial
Rx only
NDC 49315-008-03
DOXOrubicin Hydrochloride Liposome Injection
20 mg/10 mL
(2 mg/mL)
Cytotoxic Agent Must be diluted
LIPOSOMAL FORMULATION – DO NOT SUBSTITUTE FOR DOXORUBICIN HCL
FOR INTRAVENOUS INFUSION ONLY
Sterile
Refrigerate at 2⁰ to 8℃ (36⁰ to 46℉)
Do not freeze
10 mL Single-Dose Vial
Rx only
NDC 49315-009-07
DOXOrubicin Hydrochloride Liposome Injection
50 mg/25 mL
(2 mg/mL)
Cytotoxic Agent Must be diluted
LIPOSOMAL FORMULATION – DO NOT SUBSTITUTE FOR DOXORUBICIN HCL
FOR INTRAVENOUS INFUSION ONLY
25 mL Single-Dose Vial
Rx only
NDC 49315-009-07
DOXOrubicin Hydrochloride Liposome Injection
50 mg/25 mL
(2 mg/mL)
Cytotoxic Agent Must be diluted
LIPOSOMAL FORMULATION – DO NOT SUBSTITUTE FOR DOXORUBICIN HCL
FOR INTRAVENOUS INFUSION ONLY
Sterile
Refrigerate at 2⁰ to 8℃ (36⁰ to 46℉)
Do not freeze
25 mL Single-Dose Vial
Rx only
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride injectable, liposomal |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride injectable, liposomal |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Zydus Lifesciences Limited (650348852) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Zydus Lifesciences Limited | 650348852 | ANALYSIS(49315-008, 49315-009) , MANUFACTURE(49315-008, 49315-009) |